[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100622640":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":29,"centralContacts":39,"locations":48,"responsibleParty":67,"collaborators":26,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":73,"acronym":26,"eligibilityCriteria":74,"healthyVolunteers":75,"sex":76,"minAge":77,"maxAge":78,"enrollmentInfo":79,"targetDuration":26,"studyType":82,"phases":83,"briefSummary":85,"conditions":86,"keywords":89,"overallStatus":51,"whyStopped":26,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"Seppic","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"WPLC","EXPERIMENTAL","Dietary supplement - Wheat Polar Lipid Complex",[13],"Dietary Supplement: Wheat Polar Lipid Complex",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo","PLACEBO_COMPARATOR","Dietary supplement - Placebo",[19],"Dietary Supplement: Placebo",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DIETARY_SUPPLEMENT","Wheat Polar Lipid Complex","The study foresees the intake of 1 capsule per day during 12 weeks",[9],null,{"type":22,"name":15,"description":24,"armGroupLabels":28,"otherNames":26},[15],[30,34,37],{"name":31,"affiliation":32,"role":33},"Louise Deldicque, Pr","Université Catholique de Louvain","STUDY_DIRECTOR",{"name":35,"affiliation":32,"role":36},"Sylvie Copine, Dr","PRINCIPAL_INVESTIGATOR",{"name":38,"affiliation":32,"role":36},"Laurent Simar, Dr",[40,45],{"name":41,"role":42,"phone":43,"phoneExt":26,"email":44},"Valérie Dormal, PhD","CONTACT","+32(0)10 47 93 05","valerie.dormal@uclouvain.be",{"name":31,"role":42,"phone":46,"phoneExt":26,"email":47},"+32(0)10 47 44 43","louise.deldicque@uclouvain.be",[49],{"facility":50,"status":51,"city":52,"state":53,"zip":54,"country":53,"countryCode":55,"cosmosGeoPoint":56,"geoPoint":61,"contacts":62},"Center of Investigation in Clinical Nutrition (CICN)","RECRUITING","Louvain-la-Neuve","Belgium","1348","BE",{"type":57,"coordinates":58},"Point",[59,60],4.61443,50.66829,{"lat":60,"lon":59},[63,64,65,66],{"name":41,"role":42,"phone":43,"phoneExt":26,"email":44},{"name":31,"role":42,"phone":46,"phoneExt":26,"email":47},{"name":35,"role":36,"phone":26,"phoneExt":26,"email":26},{"name":38,"role":36,"phone":26,"phoneExt":26,"email":26},{"type":68,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100622640","exploration-of-the-effect-of-a-wheat-polar-lipid-complex-on-vaginal-dryness-in-healthy-postmenopausal-women-100622640",false,"NCT07386249","Exploration of the Effect of a Wheat Polar Lipid Complex on Vaginal Dryness in Healthy Postmenopausal Women","Inclusion Criteria:\n\n* Healthy woman, aged of 45 to 65 years (inclusive)\n* In postmenopause, defined according to the STRAW criteria as the absence of menstrual periods for at least 12 consecutive months\n* Reporting a vaginal dryness intensity score ≥ 4 on a 0-10 Visual Analogue Scale (VAS), and a score ≥ 16 on the Menopause Rating Scale (MRS)\n* Provision of signed and dated informed consent form\n* Stated willingness to comply with all study procedures and availability for the duration of the study\n* Stated willingness to maintain their usual life habits (diet, physical activity, alcohol consumption…)\n* Speaking French.\n\nExclusion Criteria:\n\n* Use of systemic hormonal therapy within the past 3 months\n* Use of dietary supplements, herbal products, or over-the-counter remedies intended to alleviate menopausal symptoms within 4 weeks prior to the screening visit (wash-out period ≥ 1 month required)\n* Use of vaginal hormonal formulations within 4 weeks prior to screening\n* History of hormone-dependent cancers\n* History of hysterectomy or bilateral oophorectomy\n* Current alcohol dependence or excessive alcohol consumption exceeding an average of 14 standard drinks per week\n* Current use of illicit drugs or recent history of drug dependence\n* Current or previously diagnosed eating disorders considered likely to impact participant safety or study outcomes\n* Presence of severe or uncontrolled chronic medical conditions, or any acute medical condition judged by the investigator to potentially interfere with the MRS assessment or participant safety\n* Subject participating in another intervention trial",true,"FEMALE","45 Years","65 Years",{"count":80,"type":81},110,"ESTIMATED","INTERVENTIONAL",[84],"NA","This study aims to explore the positive effect of a dietary supplement composed of wheat polar lipids on vaginal dryness in healthy postmenopausal women",[87,88],"Vaginal Dryness","Menopause Symptoms",[90,91,92],"Menopause","Wheat polar lipids","Vaginal dryness","2026-04-22",{"date":95,"type":96},"2026-04-23","ACTUAL",{"date":98,"type":96},"2026-02-02",{"date":100,"type":81},"2026-11",{"name":5,"class":6},1]